JVIM 2017 Flashcards

1
Q

Author: Fernandez/Chon
Which melphalane regime is recommended?
Which prognostic factors were identified?
What was MST?

A
  1. Daily and pulse dose = well tolerated and similarly effective
  2. Renal disease, NLR = neg
  3. 930 days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Does Mq and lymphocyte infiltration impact survival in dogs with OSA?

A

Yes, over 4.7% infiltration of Mqs has been associated with prolonged survival. Lymphocyte infiltration count did not impact ST.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which chemotherapy protocol has been used in dogs with intranasal tumours with some documented benefit?

A

Alternating doxo and carboplatin and piroxicam.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which tumour type is the most common sinonasal tumour in dogs?

A

Carcinomas (2/3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How many dogs with sinonasal tumours developed grade 3 or 4 toxicities from the carbo/doxo/prioxicam protocol?

A

25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How many dogs with low grade kuipel MCT have metastatic disease on presentation?

A

15-20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Deficiency in which enzyme may increase the risk of neurotoxicity in dogs treated with 5-FU?

A

DPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the mechanism of action for 5-FU?

A

Thymidylate synthase inhibitor

incorporation of drug metabolites in DNA and RNA results in DNA strand breaks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Is concurrent administration of carboplatin and 5-FU considered a safe treatment option?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are Merkel cell carcinoma?

A

A malignant cutaneous carcinoma found in cats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which IHC markers would you use for Merkel cell carcinoma?

A

Cytokeratin, p63, synaptophysin, and CK18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the recurrence rate and MST for cats with Merkel cell carcinoma?

A

11/17 had recurrencee, the MST was 8 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the proteasome?

A

Proteins involved in marking intracellular proteins for degradation. Tumour cells have shown a much higher sensitivity to inhibition of the proteasome proteins than normal cells- mechanism unclear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which two proteasome inhibitors are FDA approved and which tumours doe they work for?

A

Bortezomib and carfilzomib for mantle cell lymphoma and multiple myeloma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

For which canine cell lines have proteasome inhibitors shown promise?

A

melanoma and OSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name 7 important cellular processes in which proteasome function is essential making them a potential treatment target?

A
NF-kappa- B activation
Apoptosis
Cell cycle regulation
Signal transduction 
Oncogenic transformation
unfolded protein response
Chemo and radiation sensitivity
17
Q

Name 3 types of enzyme inhibitor therapy and an example of use?

A
  1. PARP-inhibitor: co-administered in HER-2 positive breast cancer
  2. Proteasome inhibitor- bortezomib, OSA and melanoma
  3. HDACi - velporic acid, vorinostat, romidepsin - OSA cell lines, cutaneous T- cell lymphoma

3.

18
Q

What is a potential complication of proteasome inhibitor treatment?

A

Impaired bone growth

19
Q

What is MCM7 and how does in relate to histological grade in cutaneous MCT?

A

IT is a novel proliferation marked for cutaneous MCT and has been found to be significantly associated with prognosis, independently of histological grade

20
Q

What was sensitivity and specificity for MCM7 (new proliferation marked in canine cutaneous MCT)?

A

Sens -83 % and spes 86%

21
Q

What is the reported sensitivity and specificity for identification of LN mets on CT to the mandibular and medial retropharyngeal LN in dogs with oral and nasal tumours?

A

10% sensitivity and 90% specificity

22
Q

Name 4 canine cancer forms in which miRNA deregulation has been identified?

A

Mammary carcinoma, lymphoma, melanoma, osteosarcoma, HS, carcinoma, MCT, TCC, Oral SCC and prostate cancer

23
Q

What is the role of aluminium in tumorigenesis?

A

Studies in cell lines have found associations between aluminium and DNB, and suggestions have been made that aluminium may contribute in an inflammatory-independent role

24
Q

What would you estimate in MST for a dog with a sinonasal tumour treated with SRT?

A

10-20 months

(bases on the 3 papers from glasses, kubiceck and geiger.

25
What are the most prevalent late effects of SRT for dogs treated for sinonasal tumours?
5/29 - fistula formation and fungal rhinitis
26
What is the MOA of combretastatin A4-phosphate?
IT is a vascular disruption agent - safety study for dosing performed in dogs )52-75 mg/m2)
27
What is the effect of TOC in dogs with metastatic OSA?
Poor, a 17% reported- with DFP of 2 mnd and MST 3 mnd
28
What was the reported median survival time for cats with gastrointestinal MCT?
530 days = 17 months
29
What is the typical presentation of an intestinal MCT on ultrasound in a cat?
present in the small intestine, focal, non-circumferential, eccentric mass.
30
T/F there is a strong benefit of surgical removal and/or chemotherapy of primary intestinal MCT in cats
F- no significant difference was found associated with survival when comparing cats that did have surgery to not, and whose that received chemo or not.
31
How predictive is the use of ration-size and precontrast attenuation in predicting LN metastasis to the sternal LN on CT=
100 % specificity and predictive value.
32
What is the most common primary intraocular tumour in dogs?
Uveal melanoma
33
What is SRC, and which canine tumour has mutations been documented?
It is an oncogene and has been found in melanoma cells
34
What is MAO of bosutinib?
TK inhibitor
35
How is the inter and intraobserver agreement in histological assessment of STS=
There is good intraobserver assessment of STS (0.78-0.9), however the interobserver agreement is moderate (0.6-0.43)